Amphina Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 5 Year, 1 Day
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 6945.75%
- Profit Growth 12685.30%
- Ebitda 127.63%
- Net Worth 156.78%
- Total Assets 156.61%
About Amphina Therapeutics
Amphina Therapeutics Private Limited (ATPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 2020 (Five years 1 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dhruv Desai, Vishal Jain, Govindsingh Chavda, and One other member serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100GJ2020PTC112901
- Company No.
112901
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Amphina Therapeutics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Jain  | Director | 03-Mar-2020 | Current |
| Pankaj Singh | Director | 06-Aug-2021 | Current |
| Dhruv Desai | Additional Director | 20-Aug-2024 | Current |
Govindsingh Chavda  | Whole-Time Director | 24-Feb-2020 | Current |
Financial Performance of Amphina Therapeutics.
Amphina Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 6945.75% increase. The company also saw a substantial improvement in profitability, with a 12685.3% increase in profit. The company's net worth Soared by an impressive increase of 156.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amphina Therapeutics?
In 2023, Amphina Therapeutics had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Innovate Lifesciences Private LimitedVishal Jain and Govindsingh Chavda are mutual person
Infinion Biopharma LimitedVishal Jain, Govindsingh Chavda and 1 more are mutual person
Axgen Chemicals Private LimitedDhruv Desai is a mutual person
- Infinion Lifesciences Private Limited
Vishal Jain is a mutual person
- Axon Hospitality Private Limited
Govindsingh Chavda is a mutual person
- Axon Group Holdings Private Limited
Govindsingh Chavda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amphina Therapeutics?
Unlock and access historical data on people associated with Amphina Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amphina Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amphina Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
